Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose versus standard-dose magnesium sulfate infusion in pediatric asthma exacerbation
TCTR20191118001Phase 3Enrolling by invitation
- Sponsor
- Thammasat University Faculty of Medicine
- Start
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of magnesium sulfate in asthma, sponsored by Thammasat University Faculty of Medicine. Started Jul 2019; status: enrolling by invitation.
02
Drugs
magnesium sulfate
03
Conditions
asthma
Beyond the preview
Go deeper on TCTR20191118001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20191118001.